Pretty solid results IMHO. Adjustments to normalise the result would be plus 1M for A-Shed full year, plus another $1M (or more) for Redfern, plus a bit for Queensland. Looking to FY23 add $3M-$4M for Coors etc and we're in the $14M ballpark for EBITDA.
Looking at the market share numbers they've done very well cf others, and noting the ongoing lockdowns and capacity limitations that appear to be behind us, this is much better than I would have expected 8 months ago. I say ... Well Done!
- Forums
- ASX - By Stock
- GDA
- Ann: FY22 Results
Ann: FY22 Results, page-18
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GDA (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
-0.005(1.85%) |
Mkt cap ! $35.01M |
Open | High | Low | Value | Volume |
27.5¢ | 27.5¢ | 26.5¢ | $816 | 3.068K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 4347 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.265 |
7 | 139570 | 0.260 |
2 | 100021 | 0.255 |
2 | 14223 | 0.250 |
1 | 3660 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 4347 | 1 |
0.285 | 3865 | 1 |
0.290 | 22375 | 2 |
0.300 | 7941 | 1 |
0.310 | 5481 | 2 |
Last trade - 10.54am 10/10/2024 (20 minute delay) ? |
Featured News
GDA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online